HOME >> MEDICINE >> NEWS
Rice nanophotonics lab gets $3 million training grant

HOUSTON, July 12, 2005 Rice University's Laboratory for Nanophotonics (LANP) has been awarded a highly competitive, five-year, $3 million federal grant for a program to prepare students in the design and fabrication of nanoscale optical components and their applications in emerging technologies.

Nanophotonics, the development of new ways to generate and manipulate light using ultrasmall, engineered structures -- some as tiny as a strand of DNA -- is one of the fastest growing fields in nanotechnology. Nanophotonics spans the disciplines of physics, chemistry, electrical engineering and bioengineering, and it holds promise for important technological advances in industries as diverse as microelectronics, magnetic recording, biomedicine, environmental remediation and homeland security.

The purpose of the training program is to create leaders with the technical and professional skills needed to achieve research breakthroughs in this emerging area and to apply them to a broad range of advanced technologies. The grant was awarded by one of the National Science Foundation's (NSF) most competitive programs, the Integrative Graduate Education and Research Training (IGERT) program.

"Rice has long been known for cross-cutting interdisciplinary research in emerging fields such as biomedicine, information technology and nanotechnology," said LANP Director Naomi Halas, the Stanley C. Moore Professor of Electrical and Computer Engineering and professor of chemistry. "Nanophotonics is proving to be a highly valuable new approach in advancing all these technologies. Our nanophotonics program includes leading theorists and experimentalists in both the basic and applied sciences, and the IGERT award recognizes that we have one of the nation's top programs."

A major focus of Rice's program is graduate training in the design, fabrication, and use of nanoscale optical components that are compatible with living systems. Key program elements include a core
'"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
12-Jul-2005


Page: 1 2 3

Related medicine news :

1. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
2. Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
3. FPG receives $8 million for autism research
4. CIRM awards $3.79 million to Burnham Institute
5. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
6. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
7. Mayor of New York proposes preventing 100 million deaths from tobacco
8. Menzies School of Health Research receives $5.3 million in Federal Budget
9. $30 million boost to dementia research
10. $1.5 million awarded for palliative care research
11. $7.5 million NIH grant to Yale for Autism Center of Excellence

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rice nanophotonics lab gets million training grant

(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... 04, 2015 FDA’s New Inspection Approach:, ... Webinar**, March 24, 2015 — 1:30 p.m. – 3:00 ... know within four hours of an inspection whether a ... on their “good” list, they’ll merely ask for reassurance ... is on the “bad” list, the manufacturer must get ...
(Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
(Date:3/4/2015)... March 04, 2015 With the growing influence ... lives of our teens and young adults, combined with the ... and confusing to try to keep up with what kids ... or trend is replaced on a daily basis. , The ... and the slang that is used to discreetly talk about ...
(Date:3/4/2015)... York (PRWEB) March 04, 2015 More ... the cardiovascular risks potentially associated with low testosterone treatments ... (FDA) announced that it will now require manufacturers to ... their risk for heart attacks and strokes. In a ... the agency also stated that it was requiring testosterone ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4
(Date:3/4/2015)... , March 4, 2015  NxStage Medical, Inc. (Nasdaq: ... today announced that Jeffrey H. Burbank , Chief Executive ... in Miami, FL on Wednesday, March ... webcast of the event will be made available at ... About NxStage NxStage Medical, Inc. (Nasdaq: ...
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)...  Results of the recent study, Results From ... Intra-Operative Positive Margin Detection , were presented as part ... Annual Miami Breast Cancer Conference last week. ... , MD, FACS, Professor of Surgery at the Sackler ... analysis of MarginProbe,s efficiency and accuracy when used consecutively ...
Breaking Medicine Technology:NxStage to Present at the Barclays Capital Global Healthcare Conference 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases 2
Cached News: